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Abstract
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Smoking prevalence among individuals with mental and behavioral health needs is considerably
higher compared to the general population, but evidence-based smoking cessation therapies are
underutilized in mental and behavioral healthcare settings, despite the fact that these treatments are
both safe and effective. The goal of this paper is to present the background, design and pilot of
Project TEACH (Tobacco Education and Cessation in the Health System) developed to improve
clinical practice by offering specialized training in the provision of smoking cessation
interventions to care providers in community mental health centers in Texas. This is achieved
through engaging the expertise of clinicians at the MD Anderson Cancer Center’s Tobacco
Treatment Program and disseminating this expertise to care providers by means of a novel telementoring approach called Project ECHO (Extension for Community Healthcare Outcomes).
Evaluation of our pilot ECHO training project demonstrated that the training was very well
received and resulted in self-reported enhancement of the providers’ professional practice. This is
the first project to extend the collaborative ECHO model to train healthcare providers in smoking
cessation. This approach has potential to reduce smoking rates among smokers with mental and
behavioral health needs, and consequently contribute to the prevention of cancer and other chronic
diseases in this vulnerable population.
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The goal of this paper is to present the background, design and pilot of a project developed
to improve clinical practice related to smoking cessation in community mental and
behavioral healthcare settings. Since the peak of smoking around the middle of the twentieth
century, smoking prevalence in the United Stated has been declining and reached 15.1% in
2015 (Jamal et al., 2016), while the smoking rate in Texas, which is the site of the project to
be presented, is 15.9% (TBRFSS, 2015). Because smoking accounts for the overwhelming
majority of all tobacco use (Agaku et al., 2014), “smoking” and “tobacco use” will be used
interchangeably hereafter. Smoking rates, while declining, are not distributed evenly across
different population subgroups and are increasingly concentrated among vulnerable and
underserved populations (Jamal et al., 2016). Of particular concern is the population with
mental illness, whose average smoking prevalence rates have been estimated to be 36.1%
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nationally and 33.9% in Texas, in the 17.3% of the state’s population that suffer from a
diagnosable mental disorder (Gfroerer, Dube, King, Garrett, & Babb, 2013). Alarmingly,
smoking rates increase with severity of mental illness and may be as high as 64–79% among
individuals with serious mental illness (SMI), defined as a mental, behavioral or emotional
disorder that meets diagnostic criteria specified in the Diagnostic and Statistical Manual and
results in serious functional impairment (Annamalai, Singh, & O’Malley, 2015; Evins &
Cather, 2015; McClave, McKnight-Eily, Davis, & Dube, 2010; Roberts, Evins, McNeill, &
Robson, 2016). Persons with mental illness also smoke more cigarettes per day than those
without mental disorders (McClave et al., 2010) and suffer from disproportionate smokingrelated health consequences, including cancer incidence and mortality, mirroring their
elevated smoking rates and higher cigarette consumption (Baughman et al., 2016; Kisely,
Crowe, & Lawrence, 2013; McGinty et al., 2012; Schroeder & Morris, 2010). Consequently,
individuals with mental illness, especially those with SMI, can benefit from smoking
cessation even more than smokers without comorbidities.

Author Manuscript
Author Manuscript

Evidence-based smoking cessation therapies are available. The 2008 Treating Tobacco
Dependence Clinical Practice Guideline (Fiore et al., 2008) recommends that all smokers,
including those with comorbid psychiatric disorders, be offered treatment for tobacco use
and dependence. The 5A’s counseling model recommended by the Guideline applies to this
population as well and all clinicians who treat individuals with mental and behavioral
healthcare needs are encouraged to Ask the patient if he/she uses tobacco, Advise that he/she
quit, Assess his/her willingness to quit, Assist in making a quit attempt and Arrange a
follow-up (Fiore et al., 2008). Smoking cessation treatments have been proven to be both
effective and safe among individuals with mental illness (Annamalai et al., 2015; Hall &
Prochaska, 2009). However, the relationship between tobacco dependence and psychiatric
disorders is complex (Aubin, Rollema, Svensson, & Winterer, 2012). The high cooccurrence between the two may be explained, in part, by a genetic vulnerability to
addiction and mental illness (de Viron, Morré, Van Oyen, Brand, & Ouburg, 2014), and by
the hypothesized self-medication to alleviate psychiatric symptoms or to relieve adverse
side-effects of psychotropic medications (Annamalai et al., 2015; Aubin et al., 2012). Given
this complexity as well as the significantly higher levels of tobacco dependence in this
population, tobacco use treatment for smokers with mental illness, especially SMI, may
necessitate more intensive and individualized pharmacological and behavioral treatment
approaches (Hall & Prochaska, 2009). Smokers with mental illness may require higher doses
of smoking cessation medications, combined therapies and longer duration of treatments
(Annamalai et al., 2015; Evins & Cather, 2015; Fiore et al., 2008). Since nicotine influences
multiple neurochemical processes as well as metabolism of psychiatric medications (Aubin
et al., 2012; Wu et al., 2008), medication side effects, blood levels, and symptoms of mental
illness need to be monitored closely during smoking cessation so medication dosage can be
adjusted accordingly (Fiore et al., 2008). With that in mind, it is important to note the lack of
evidence for exacerbation of psychiatric symptoms during the course of smoking cessation,
which also holds true for patients with SMI (Annamalai et al., 2015; Aubin et al., 2012;
Evins & Cather, 2015; Hall & Prochaska, 2009; Roberts et al., 2016).
Despite availability, effectiveness and safety of smoking cessation treatments for smokers
with mental illness, along with evidence that these patients, including ones with SMI, are
Cogent Med. Author manuscript; available in PMC 2019 February 08.
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both motivated and able to quit successfully (Annamalai et al., 2015; Dickerson et al., 2011;
Hall & Prochaska, 2009), the treatment for tobacco use and dependence is generally
neglected in mental and behavioral healthcare settings (Brown et al., 2015; Himelhoch,
Riddle, & Goldman, 2014; Ziedonis et al., 2008). A survey of clinicians in nine community
mental health centers revealed that the majority did not ask their patients about smoking,
less than a third advised or assisted with smoking cessation, and very few referred identified
smokers to a telephone quitline (Himelhoch et al., 2014). Further, results of a large survey of
healthcare providers (Association of American Medical Colleges [AAMC], 2007) indicated
that psychiatrists were considerably less likely to participate in smoking cessation practices
related to the 5A’s compared to primary care specialties (family, internal and ObGyn).

Author Manuscript

There are both actual and perceived barriers to the delivery of smoking cessation treatment
by mental health providers (i.e., psychiatrists, advanced-level providers, nurses, and
counselors). First, considering the complex association between tobacco dependence and
psychiatric disorders, many clinical providers who work in mental and behavioral healthcare
settings lack the necessary training and experience in smoking assessment and cessation
interventions for their target population (AAMC, 2007; Hall & Prochaska, 2009; Himelhoch
et al., 2014). Consequently, these providers report low levels of confidence in their ability to
counsel and help smokers to quit (Himelhoch et al., 2014). Second, many mental health
providers hold certain assumptions about patients who smoke and about smoking cessation
that hinder the delivery of treatment in this population. Among such barriers, the most
strongly endorsed is the perceived lack of patient interest in smoking cessation (Brown et al.,
2015; Hall & Prochaska, 2009; Himelhoch et al., 2014), a notion which research disproved
(Annamalai et al., 2015; Dickerson et al., 2011; Hall & Prochaska, 2009).
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Some mental health providers also believe that patients have more immediate diagnostic
problems to address and that cessation efforts will worsen patients’ psychiatric symptoms
(AAMC, 2007; Himelhoch et al., 2014). The latter view is not supported by evidence, either
(Annamalai et al., 2015; Aubin et al., 2012; Evins & Cather, 2015; Hall & Prochaska, 2009;
Roberts et al., 2016). Finally, all of the barriers mentioned above are exacerbated by other
competing practice priorities, perceived or actual lack of time to address smoking cessation,
low availability or lack of knowledge of resources for referral, and issues surrounding cost
and insurance coverage of smoking cessation treatment (AAMC, 2007; Hall & Prochaska,
2009; Himelhoch et al., 2014). A majority of these barriers can be overcome through
training and education (Brown et al., 2015; Hall & Prochaska, 2009; Himelhoch et al.,
2014).
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The goal and objectives of the current project endeavor to address the problem of insufficient
treatment of tobacco use and dependence in mental and behavioral healthcare settings. The
goal of the project is to improve clinical practice in this area through developing and
providing specialized training in intensive and personalized interventions for smokers with
mental illness to mental health providers in Local Mental Health Authorities (LMHAs) in
Texas. Specific objectives of the project are detailed below.
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2. Community-based mental healthcare in Texas
A large proportion of mentally ill individuals in Texas are treated in community mental
health centers called LMHAs. These LMHAs provide services under the auspices of the
Texas Department of State Health Services (TDSHS) to patients with SMI in a specific
geographic area referred to as the local service area (TDSHS, 2016; TSOS, 2016). There are
39 LMHAs in Texas that have oversight of more than 680 individual treatment clinics
throughout the state and provide services to almost 500,000 patients per year. As such, the
LMHAs and the associated clinics represent an ideal setting in which to intervene with
Texans who have mental and behavioral healthcare needs to reduce their tobacco use.
Results from two surveys administered to the LMHAs indicated that smoking status was
rarely assessed in these clinics and smoking cessation interventions were seldom
incorporated into the treatment plan.

Author Manuscript

3. Taking Texas Tobacco Free

Author Manuscript

The opportunity to promote tobacco cessation within LMHAs was pursued by state
policymakers and TDSHS mandated that all LMHA clinics in Texas become tobacco-free
campuses. At the same time, one of the LMHAs, the Austin Travis County Integral Care
(ATCIC), developed a comprehensive educational and treatment-focused plan that was
implemented to reduce smoking among patients. The program had a dramatic impact on
beliefs and practice behaviors at ATCIC, with 81.6% of employees feeling adequately
trained for the implementation of the tobacco-free campus policy and 46.4% patients
screened for smoking status receiving cessation advice and taking concrete steps to quit. To
capitalize on this success and to disseminate ATCIC’s program to other LMHAs, two coauthors of the present paper, Drs. Lorraine Reitzel and Cho Lam, in collaboration with
ATCIC, implemented a program called Taking Texas Tobacco Free (TTTF): Expanding the

Integral Care Campus and Community Model into a Statewide Cancer Prevention Program.

Author Manuscript

The overarching goal of TTTF was to disseminate and implement a comprehensive tobaccofree workplace program to select LMHAs across Texas (Samaha et al., 2017). Specifically,
TTTF set out to provide assistance to LMHAs with implementation of the tobacco-free
policy, educate LMHAs’ employees about the hazards of smoking, and increase the
frequency of smoking assessments of all patients as well as the delivery of basic smoking
cessation advice and brief interventions to LMHAs’ patients who smoke. To date, TTTF has
assisted with the implementation of the tobacco-free policy and the integration of smoking
assessment and cessation into clinical practice across 19 LMHAs. However, considering the
complexity of the association of smoking and smoking cessation with mental illness, the
LMHA providers were in need of on-going training in more intensive and personalized
approaches that are essential to assist patients with mental illness who smoke. From this
need came the idea of the current project.

4. Project TEACH
In 2014, faculty members at MD Anderson Cancer Center (MD Anderson) at Houston,
Texas, Drs. Paul Cinciripini and Janice Blalock, in collaboration with Dr Maher Karam-
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Hage and partners at Rice University, the University of Houston and ATCIC, obtained
funding from the MD Anderson Moon Shot Program to develop Project TEACH: Tobacco
Education and Cessation in the Health System. The goal of Project TEACH, to offer
specialized smoking cessation training to LMHA providers, is realized through the following
objectives: (1) to increase LMHA providers’ knowledge and self-efficacy to treat smoking
cessation, especially with regards to complex, specialized treatments tailored for the
individual needs of smokers with mental illness; (2) to improve LMHA providers’ practice
behaviors with regards to the full spectrum of the recommended evidence-based smoking
cessation practices (the 5A’s; Fiore et al., 2008), and (3) to increase the proportion of
LMHAs’ patients who succeed in abstaining from smoking. It is important to note that
Project TEACH, including the pilot described below, is a quality improvement project
approved by the MD Anderson Quality Improvement Assessment Board. It does not require
Institutional Review Board approval, because it is not intended as hypotheses-testing
research and does not contribute to generalizable knowledge. It can collect relevant data
anonymously and report it only in aggregate as it pertains to the entire project and its pilot.
Project TEACH operates with oversight from two components of the MD Anderson Moon
Shot Program, the Lung Moon Shot and the Cancer Prevention and Control Platform. There
are two pillars which support Project TEACH: the MD Anderson Tobacco Treatment
Program and Project ECHO. The former provides the science-based knowledge and clinical
expertise for the development and delivery of the specialized smoking cessation training and
the latter provides a collaborative model and framework for the delivery of the training.

Author Manuscript
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MD Anderson’s Tobacco Treatment Program (TTP) was established in 2006 with the
mission to provide free of charge, comprehensive, individually tailored tobacco cessation
support to cancer patients, employees, and their families who self-report as current tobacco
users or recent quitters (Rabius, Karam-Hage, Blalock, & Cinciripini, 2014). The TTP is
staffed by a clinical team including an addiction psychiatrist, a clinical psychologist, two
physician assistants, a nurse, and four smoking cessation counselors. The program provides
a range of services. The standard course of treatment consists of an intensive, 12-week,
individualized behavioral and pharmacological intervention which offers evidence-based
counseling (e.g., motivational interviewing) and pharmacotherapies (e.g., nicotine
replacement therapy (NRT), varenicline, and bupropion) to assist in smoking cessation and
to treat patients’ psychiatric comorbidity. In 2013, 40% of cancer patients treated by the TTP
met criteria for current psychiatric diagnoses. The TTP has been very successful in helping
this difficult group of patients to quit smoking. For example, in 2013, the program helped
48.4% of the patients with none or one comorbid psychiatric disorder and 41.5% of the
patients with two comorbid psychiatric disorders to achieve and maintain abstinence at the
nine month follow-up point. Therefore, the TTP is uniquely positioned to provide support
for the development and delivery of the specialized tobacco treatment training for mental
health providers in LMHAs. Project TEACH draws on the vast expertise of the TTP clinical
team including the use of advanced pharmacotherapy techniques for treating comorbid
tobacco dependence and psychiatric disorders, and expertise in behavioral counseling for
smoking cessation. This expertise is shared with the LMHAs’ mental health providers by
means of a novel tele-mentoring approach called Project ECHO.
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5. Project ECHO
The Extension for Community Healthcare Outcomes (ECHO) model was developed by Dr
Sanjeev Arora at the Health Sciences Center at the University of New Mexico to improve
access to complex chronic disease and specialty care in rural and underserved communities
(Arora et al., 2010).

Author Manuscript

First piloted for the treatment of hepatitis C virus, Project ECHO is now applied to a variety
of chronic, complex diseases and allows academic medical centers to share the specialized
knowledge and skills with community-based healthcare providers. ECHO training consists
of a series of web-based ECHO meetings which rely on tele-health technology for
participation and combine didactic presentations by specialty clinicians, case presentations
by community-based clinicians and expert-facilitated discussion of the cases (Arora et al.,
2010). Healthcare providers in the community learn about best practices and treatment for
complex diseases through the “one-to-many” tele-mentoring approach in which an academic
expert shares specialized knowledge with local providers and the “many-to-many” colearning approach where local providers learn from each other’s experience. This model is
very different both from traditional didactic training and from traditional telemedicine where
the specialist assumes the care of the patient (Arora et al., 2010).

Author Manuscript

Project ECHO lends itself exceptionally well to the dissemination of evidence-based best
practices for the treatment of tobacco use and dependence among individuals with mental
illness. As mentioned earlier, community-based mental health providers may not be familiar
with the individualized approaches needed to treat smoking cessation among smokers with
SMI. Optimal treatment and management of smoking cessation in this patient population is
achieved through consultation with specialists from several areas including addiction
psychiatry, clinical psychology, and nursing. Such consultation would be costly and
logistically difficult to deliver using traditional means, but the innovative ECHO model
provides this ongoing relationship in an easy, accessible way.

6. ECHO Training with Project TEACH

Author Manuscript

To our knowledge, Project TEACH is the first to extend the ECHO model to train providers
in smoking cessation. Under Project TEACH, clinical staff at MD Anderson offers
specialized training to LMHAs’ providers using the ECHO tele-mentoring approach which
consists of a series of ECHO meetings. The training is free of charge to the clinics and
convenient, as it uses video-teleconferencing technology and does not require travel.
Participants can join ECHO meetings from their own office or from anywhere else by a
computer, telephone or other mobile device. The training is approved for credits in
Continuing Medical Education (CME) and Continuing Nursing Education (CNE) as well as
for Continuing Education Units (CEU) for licensed non-medical personnel.
6.1. ECHO meetings
Each of a series of ECHO meetings starts with a brief didactic presentation on a specific
topic presented by one of the TTP clinicians who is an expert in the content area. Next, one
of the LMHA clinicians presents a tobacco-related case of his or her choice. The case is then
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discussed by other LMHA providers and project team members in attendance, and the
discussion is facilitated by an MD Anderson clinician. Thus, ECHO training with Project
TEACH creates an opportunity for LMHA providers to develop both content knowledge by
means of traditional didactic learning from content experts and self-efficacy through expertfacilitated, case-based learning from other LMHA providers in similar settings. Case-based
discussion with peers provides a forum for professional growth and facilitates sharing
tobacco cessation experiences across the participating LMHAs.

Author Manuscript

Each ECHO meeting lasts one hour and is delivered from an MD Anderson teleconferencing
facility. Participants join via Zoom video/web conferencing. The invitees include MD
Anderson clinicians, collaborators of Project TEACH, and LMHA clinicians including
physicians, physician assistants, advance practice nurses, registered and licensed vocational
nurses, licensed counselors, qualified mental health providers, certified peer specialists and
providers of other specialties. Each meeting is initiated by an MD Anderson ECHO
representative who reads the introduction and the presenter conflict of interest disclaimer.
The meetings are recorded and available for viewing from the Project TEACH website.
6.2. Didactic curriculum

Author Manuscript

The MD Anderson clinicians at TTP developed a series of 35 presentations for the didactic
curriculum. The topics are listed in Table 1 and are grouped into two categories: Medical
and Counseling. This arbitrary grouping is based on the focus of each presentation, which
may be more appropriate and interesting for the medical personnel including physicians,
physician assistants and nurses (e.g., smoking cessation medications and their side effects)
versus non-medical personnel such as licensed counselors or qualified mental health
providers (e.g., motivational interviewing). The Medical and Counseling topics are meant to
be presented in alternating order; however, both categories of LMHAs providers are
encouraged to attend all presentations. The presentations are prepared in PowerPoint and last
approximately 15–20 minutes. Each presentation is tailored to smokers with mental illness,
including SMI, and the providers who serve them. Importantly, the presentations address
known barriers to the delivery of smoking cessation treatment in mental and behavioral
health settings.
6.3. Case presentations and discussion

Author Manuscript

Before each ECHO meeting, MD Anderson staff solicits cases to be presented by
participating LMHA providers. There is time to present and discuss one or two cases per
ECHO meeting. Based on the pilot described below, a typical case features a middle-aged
male or female smoker or recent quitter with several mental health diagnoses including SMI
and comorbid or past addictions (usually alcohol). These disorders typically occur in the
context of serious problems related to unemployment, unstable housing, abusive
relationships, poor general health and/or lack of health insurance. Regarding the smoking
status, the patient may be unmotivated to quit, going through unsuccessful quit attempts or
struggling to maintain abstinence. Discussion following case presentation is moderated by
one of the TTP clinicians, with content experts and other LMHAs’ providers contributing to
the discussion.
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The plan to evaluate outcomes of Project TEACH draws from expertise in evaluation of
other healthcare ECHO programs (Arora et al., 2010) as well as evaluation of communitybased tobacco programs including tobacco-related training for healthcare providers
(Prokhorov et al., 2010; Starr et al., 2005). Outcomes include (1) provider participation in
ECHO training (number of sites, meetings and providers attending the meetings), (2)
provider knowledge, self-efficacy and self-reported practice behaviors related to the 5A’s of
tobacco counseling, (3) provider feedback and experience with participation in the ECHO
meetings, and (4) provider and patient tobacco-related outcomes based on the medical
record. Outcomes (2) and (3) are assessed by means of a provider survey developed by the
Evaluation Subcommittee of Project TEACH and based on best practices in evaluation of
ECHO and tobacco programs (Arora et al., 2010; Prokhorov et al., 2010; Starr et al., 2005).
Outcomes (2) and (4) are planned to be assessed at baseline, while all four categories of
outcomes will be assessed 6 months after the completion of ECHO training.

7. Project TEACH pilot
The goal of Project TEACH pilot was to conduct a small-scale test of the overall program.
The objectives were to (1) test the program and its evaluation survey at two community
centers, (2) collect and summarize descriptive data on participating providers’ self-reported
relevant knowledge, practice behaviors, experiences with and opinions about the program,
and (3) apply the data to the improvement of Project TEACH before the full-scale
implementation. This pilot is a descriptive quality improvement project rather than a
research study, because it is not hypothesis-driven and is not intended to contribute to
generalizable knowledge.

Author Manuscript

Project TEACH completed a pilot project at two community centers, ATCIC and Spindletop
Center. During the pilot ECHO training, 16 ECHO meetings were offered with presentation
topics # 1–7 and 11–20 (Table 1). Meetings occurred weekly between April 27, 2015 and
July 13, 2015, and biweekly from September 15, 2015 to December 1, 2015 with a break in
August 2015, during which the interim pilot survey for providers was administered. Twenty
three LMHAs providers attended at least one meeting of Project TEACH pilot ECHO (Table
2) and brought a total of 12 de-identified cases to the ECHO meetings.

Author Manuscript

The pilot has been followed by refinement of the evaluation strategy, development of
additional didactic presentations and relationship building as part of the recruitment of
LMHA clinics into the main phase of the project which focuses on the provision of ECHO
training with Project TEACH to the 19 LMHAs that participated in the TTTF project. For
relationship building, Project TEACH relies on the experience of ATCIC team which has
developed and maintained excellent relationships with leadership and staff of all LMHAs.
7.1. Pilot survey results
The interim pilot survey was created in Research Electronic Data Capture (REDCap), a webbased application for building and managing online surveys. It was sent to 23 LMHA
providers who had participated in ECHO meetings as of August 2015 (Table 2). Twenty two
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providers responded to the survey (96% response rate), although the number of respondents
to individual survey questions varied. The survey was anonymous and did not include any
unique participant identifiers. According to the survey, 77% of respondents had received
previous tobacco training. Not surprisingly, all respondents reported moderate or high ability
and confidence to address tobacco use and dependence among their patients who smoke,
although 7% reported low intention to do so. The majority of the knowledge questions
yielded between 69%–85% correct answers, and 54% of respondents reported that only up
to one fourth of the knowledge presented during the pilot ECHO training was new to them.
Almost 60% believed that the training enhanced at least one aspect of their professional
practice, such as knowledge, competence, performance, patient outcomes or their
professional satisfaction, and 77% agreed or strongly agreed that the overall content,
organization and quality of the program were satisfactory.
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Sixty two percent of respondents reported not having cases to present, but an overwhelming
majority (92%) felt that they learned from others who presented or discussed cases during
ECHO meetings, thus supporting the importance and value of co-learning as part of ECHO
training. Similarly, all respondents agreed that the didactic presentations added to their
knowledge of how to treat tobacco use and dependence among their patients, with 77%
endorsing the statement that the didactics provided enhanced knowledge always or most of
the time. In response to the important question whether they intended to make changes or
apply learning to their practice as a result of the program, 17% of the participating providers
reported already practicing the recommendations, 58% expressed that they plan to make
changes, but 25% were not sure and were only considering changes. No one reported not
planning to make any changes. Responses to questions about practice behaviors related to
the 5A’s were not analyzed due to the fact that some respondents entered verbal instead of
numeric responses, which interfered with data extraction from REDCap software. This has
been resolved for subsequent surveys by designing coded multiple choice response options
for these important outcomes.
The survey generated 21 qualitative comments. Six comments (29%) described practice
changes that the respondents intended to make (e.g., incorporate Motivational Interviewing
techniques, allow more time for delivering tobacco cessation education to smokers during
clinic visits), 6 (29%) recommended changes to the program to make it more useful (e.g.,
more case studies, more didactics), 6 (29%) suggested topics for future presentations (e.g.,
resistance to cessation, more information about e-cigarettes), and 3 (13%) were general
comments (e.g., program well organized, new knowledge appreciated).

Author Manuscript

Overall, this was a highly motivated sample of providers, with the majority well versed in
the tobacco-related topics. This was most likely a reflection of high participation of tobacco
specialists already trained in smoking cessation.
7.2. Barriers and next steps
Project TEACH subsequently offered ECHO training to other LMHAs in 2016 and 2017.
Based on the pilot data, several barriers were identified prior to the full-scale
implementation of Project TEACH. How these barriers were addressed will be described in
a separate paper (in preparation). Among the barriers, participation of medical prescribers in
Cogent Med. Author manuscript; available in PMC 2019 February 08.
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Project TEACH pilot ECHO training was not optimal. This may have been due in part to
LMHAs investing in tobacco specialists who are exclusively dedicated to counseling
smokers. This model may reinforce the perception among the medical personnel that
smoking cessation among their patients can be addressed without their participation.
However, the main issue related to participation by medical personnel is the heavy load of
clinical work. As one of the survey respondents put it, “clinicians should have dedicated
time to attend” the ECHO training. This cannot possibly happen without buy-in and support
from the leadership of LMHA clinics.
An important barrier to effective tobacco cessation treatment was the need to provide NRT
and other smoking cessation medications to LMHA patients free of charge as the majority
have limited or no insurance coverage. The TTTF project provided NRT free of charge to
participating LMHAs, but the supply was quickly exhausted at numerous clinics.

Author Manuscript
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Another set of barriers identified in the pilot was related to evaluation data collection.
Evaluation objectives included collecting data on patient smoking abstinence outcomes via
the medical record. However, a closer examination by Project TEACH Evaluation
Subcommittee revealed some obstacles. While most LMHAs do assess tobacco use among
their patients, they each have their own medical record and their tobacco use assessment
forms may differ, resulting in differences in data obtained from different LMHAs. Also,
extraction of any data from the medical record would impose excessive burden on staff in
the clinics. In working with community partners in real-life settings, their primary mandate,
which in this case is service to their patients, always comes first and any objectives of a
collaborative project that are not feasible in this context need to be revised. As a result, plans
to collect medical record data were deferred, to be revisited if any of the proposed measures
are feasible to collect in any of the participating clinics.

8. Summary

Author Manuscript

The importance of Project TEACH lies in the dissemination and implementation of
evidence-based clinical practice for smoking cessation which had already been researched
elsewhere and proven to be effective. Dissemination and implementation of this practice
among healthcare providers who serve persons with mental and behavioral healthcare needs
helps alleviate the disproportionate burden of smoking and the resulting diseases in this
population. Project TEACH partners with mental health community centers to build new and
sustainable capacities, which will help the clinical providers to better serve their patients
who smoke by becoming better skilled in smoking cessation intervention. Results of Project
TEACH pilot survey conducted in two community centers confirmed usefulness and
acceptability of the program. By equipping healthcare providers with specialized knowledge
and self-efficacy to use tailored smoking cessation treatments with their patients, Project
TEACH intends to reduce smoking prevalence among Texans with mental and behavioral
healthcare needs and ultimately prevent cancer and other chronic diseases in this vulnerable
population.
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Summary of didactic presentations created for ECHO training with Project TEACH
Medical Didactic Presentations

Author Manuscript

1

Neurobiology of Nicotine Dependence

2

Selecting the Optimal Tobacco Cessation Medication

3

Overview of First-Line Tobacco Cessation Medications

4

Common Beliefs About Smoking Cessation in Psychiatric Patients

5

E-cigarettes: What are They and Their Impact on Mental Health?

6

Varenicline (Chantix): The Evolving Understanding of its Psychiatric and Cardiovascular Effects

7

Tobacco Control Among Youth: Emphasis on Mental Disorders

8

First Line Smoking Cessation Medications: Recognizing and Managing Side Effects

9

Cardiovascular and Psychiatric Adverse Events Associated with NRT and Bupropion

10

Pathways for Treating Tobacco Use in the Clinic

11

Benefits of Quitting Tobacco

12

Addressing Tobacco Treatment for Pregnant Women

13

Tobacco Treatment with People Receiving Substance Abuse Treatment

14

Ethics

15

Tobacco Cessation Among People with Schizophrenia and Bipolar Disorder

16

Tobacco Cessation Among People with Depression

Counseling Didactic Presentations

Author Manuscript
Author Manuscript

17

Intake Assessment

18

Introduction to the Importance of Tobacco Cessation in Psychiatric Patients

19

Motivational Interviewing: A Brief Overview

20

Motivational Interviewing: A Brief Overview Part 2

21

Motivational Interviewing: A Brief Overview Part 3—Open-Ended Questions

22

Managing Anxiety Associated with Withdrawal

23

Motivational Interviewing: A Brief Overview Part 4—Affirmations

24

Motivational Interviewing: A Brief Overview Part 5—Reflections

25

Motivational Interviewing: A Brief Overview Part 6—Summaries

26

Motivational Interviewing: A Brief Overview Part 7—Four Oars: Putting it Together

27

Motivational Interviewing: A Brief Overview Part 8—Internal vs. External Motivation and the Rulers - Skills for Use in MI

28

Motivational Interviewing: A Brief Overview Part 9—Change Talk vs. Sustain Talk

29

Interdisciplinary Coordination of Medication Management

30

Behavioral Strategies in Tobacco Treatment: Stages of Change

31

Coping Strategies for Tobacco Cessation Part I

32

Coping Strategies for Tobacco Cessation Part II

33

Behavioral Strategies in Tobacco Treatment: Identifying Triggers

34

Relapse Prevention for Tobacco Cessation

35

Group Counseling
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Sample of LMHA providers participating in ECHO meetings and receiving Project TEACH pilot survey
Provider Type and Related Data

Number (%)

Medical Prescriber (Physician, Physician Assistant, Advanced Practice Nurse)

5 (22)

Nurse (Licensed Vocational Nurse, Registered Nurse)

7 (30)

Licensed Counselor (Licensed Professional Counselor, Licensed Clinical Social Worker, Licensed Marriage and Family
Therapist)

5 (22)

Certified Peer Specialist

2 (8.7)

Clinical Administrator

2 (8.7)

Other (Chief Medical Officer, Forensic Program Supervisor)

2 (8.7)

Total

23 (100)

Responded to Pilot Survey

22 (96)
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